about
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiationAdjuvants: Classification, Modus Operandi, and LicensingChoice and Design of Adjuvants for Parenteral and Mucosal VaccinesRegulation of Dendritic Cell Function in InflammationPolyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesJapanese encephalitis: the virus and vaccinesA recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cellsAdjuvants for peptide-based cancer vaccinesT cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccinationSystematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsDefect density in multiwalled carbon nanotubes influences ovalbumin adsorption and promotes macrophage activation and CD4(+) T-cell proliferationA novel laser vaccine adjuvant increases the motility of antigen presenting cellsComparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in miceCrucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvantsThe inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesisQuality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies.Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza.Anthrax sub-unit vaccine: the structural consequences of binding rPA83 to Alhydrogel®.Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models.Invariant NKT cells sustain specific B cell responses and memory.The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1β and IL-18 production.Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.A universal polysaccharide conjugated vaccine against O111 E. coli.Novel vaccines to human rabiesAluminum hydroxide injections lead to motor deficits and motor neuron degenerationProduction and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity.Immunomodulation of vascular diseases: atherosclerosis and autoimmunityBabassu aqueous extract (BAE) as an adjuvant for T helper (Th)1-dependent immune responses in mice of a Th2 immune response-prone strain.How advances in immunology provide insight into improving vaccine efficacy.Preparation and evaluation of niosomes containing autoclaved Leishmania major: a preliminary study.Multiparameter telemetry as a sensitive screening method to detect vaccine reactogenicity in miceA novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.Systems vaccinology.Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesA pilot clinical trial of a recombinant ricin vaccine in normal humans.Transcriptomic response of porcine PBMCs to vaccination with tetanus toxoid as a model antigenStreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes.
P2860
Q24649009-699A36D7-9280-4996-BC60-689C0640AA58Q26747586-3ED862D0-012C-45E0-B7AE-ED2894F29F8FQ26783488-7B1FF3A7-9132-4724-A47C-6ECFED723DEDQ26800988-27BA959C-1C70-4BE8-A3EA-3AACA212844CQ26852816-7B556952-4BA1-44D2-916E-C549CF26597FQ27010434-A2429AA4-6685-422C-AE0C-A2963317352FQ27487992-8C8011BA-04C8-4C19-BD4B-CF58EA3EC61AQ28072236-A54F15E6-8081-498F-B637-A4F7BEF5D8F3Q28274469-CC5C5166-7CCD-4BBC-8A02-964A7624A133Q28387541-4619B8F1-C8C9-4E96-9A78-E218B8BDD9FEQ28388944-1F65525D-BA53-44F9-9B90-354B3DA1A82CQ28475973-60C01D94-5889-488B-9E72-92EF2BAA7D6DQ28752489-1A6817BB-949F-4369-A042-E87F77C2C2D1Q29615635-40411A7E-4A59-41CD-A879-EDA2CD6B2C89Q29617049-61CA775B-A302-4594-920D-5F661409C7EBQ30362618-AAF92075-8066-43BD-9F32-39EA2CE931FFQ30377447-B4AFA186-93CA-4A3F-BBA3-AA9C6A741A9FQ30400393-8567D3A7-8DF6-4BF6-8156-BEAC45A1DD7CQ30407662-989D6029-F9ED-45B9-B014-068D419E37E3Q30418752-DD2A067A-15DA-457F-A36E-326381EA0A40Q30479030-5ED65D6A-6D88-4684-897B-32219FD31A20Q31057510-145917F0-9579-4CBE-B428-95E5051471EBQ33302902-18179148-059B-4B7D-A4BC-2FF448E5136CQ33419199-196031FC-14FA-41AC-BD42-4100DA987A38Q33507253-C243D484-D1F3-4AF8-9666-A88916B375BFQ33644364-0482BDB8-BD0D-400C-B983-6E07A4B41402Q33743450-74369870-3655-4637-90BE-5909797879F6Q33749602-51A4B78F-93B1-4BF6-9598-537210159229Q33770999-25B027EC-718D-41E5-BF04-0BDE588662A0Q33806434-33A969B9-D386-4C4B-92F5-CEF3B8644BA5Q33896995-A21BB491-358C-4436-9E7E-62996F7627F0Q34093684-5B84EBE0-9F6F-4163-B299-036A4B4CAD7AQ34140252-E32E8FEF-CE58-444F-817C-27F8D10AA468Q34359593-57502470-C0F3-4CA0-97AB-033F09E57B68Q34402910-87379EDC-DD35-45F8-AD82-F7AE68805FE2Q34455275-56C47BB0-88A7-452D-A274-C4885D8B9251Q34479216-3E9E361E-FF62-48C3-A350-461798534A3FQ34639206-BF1928C7-DD47-463B-AE9B-6B456B6343F4Q34674395-5A57EA9E-DBCD-43BD-9217-82055F121ECFQ34721210-B9FCB2FC-4214-4B19-B3D4-F930F178C4B8
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Aluminium compounds for use in vaccines.
@ast
Aluminium compounds for use in vaccines.
@en
type
label
Aluminium compounds for use in vaccines.
@ast
Aluminium compounds for use in vaccines.
@en
prefLabel
Aluminium compounds for use in vaccines.
@ast
Aluminium compounds for use in vaccines.
@en
P2860
P1476
Aluminium compounds for use in vaccines.
@en
P2093
Erik B Lindblad
P2860
P304
P356
10.1111/J.0818-9641.2004.01286.X
P577
2004-10-01T00:00:00Z